[[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium
C9H13N4O2Tl — CID 163443735
Data last refreshed: (MolForge compound catalog, from PubChem)
About [[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium
[[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium (PubChem CID 163443735) has the molecular formula C9H13N4O2Tl and a molecular weight of 413.61 g/mol. Its IUPAC name is [[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium.
Molecular Properties
| Compound Name | [[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium |
|---|---|
| PubChem CID | 163443735 |
| Molecular Formula | C9H13N4O2Tl |
| Molecular Weight | 413.61 g/mol |
| Exact Mass | 414.08 |
| IUPAC Name | [[2-amino-5-[C-(2-methoxyethoxy)carbonimidoyl]-4-pyridinyl]amino]thallium |
| SMILES | [H]/N=C(\OCCOC)c1cnc(N)cc1N[Tl] |
| InChI | InChI=1S/C9H13N4O2.Tl/c1-14-2-3-15-9(12)6-5-13-8(11)4-7(6)10;/h4-5,12H,2-3H2,1H3,(H3-,10,11,13);/q-1;+1/b12-9-; |
| InChIKey | BASWKBAJHQYMBW-MWMYENNMSA-N |
| XLogP | 0.15 |
| TPSA | 93.25 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.61 |
| LogP ≤ 5 | 0.15 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163443735 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.